Attovia Therapeutics Inc ATTO
$25.55 $1.35 (5.58%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
A
Is Attovia Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of ATTO Stock
United States N/A Small Cap No. As of September 2026, Attovia Therapeutics Inc (ATTO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Attovia Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
Attovia Therapeutics Inc is a US-based company operating in industry. The company is headquartered in San Carlos, California. The company went IPO on 2026-08-05. Attovia Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases with high unmet need. Its lead pipeline candidates target commercially validated pathways and are designed through its ATTOBODY biologics platform to deliver improved treatments relative to the standards of care. Its ATTOBODY platform uses an evolution-driven, high-throughput process which allows for discovery and creation of a high diversity of potential product candidates. The company is developing a pipeline of novel biotherapeutics for the treatment of immune-mediated diseases. Its first two product candidates for its immune-dermatology franchise, ATTO-1310 and ATTO-2306, have the potential to treat patients suffering from pruritic and lesional diseases. Its third program, ATTO-1091, broadens its reach to other inflammatory diseases, such as IBD, a therapeutic area with substantial unmet need. ATTO-1310 is an ATTOBODY-based therapeutic targeting interleukin-31.
ATTO Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Attovia Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Attovia Therapeutics Inc (ATTO) Chart
Financial Metrics & Statements of Attovia Therapeutics Inc (ATTO)
FAQ's for Attovia Therapeutics Inc (ATTO)
- As of September 2026, Attovia Therapeutics Inc ATTO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Attovia Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Attovia Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Attovia Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Attovia Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Attovia Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Attovia Therapeutics Inc (ATTO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
